Centessa Pharmaceuticals
MA - Boston
PharmaceuticalFocus: Umbrella company acquiring drug companies
Centessa Pharmaceuticals is a life sciences company focused on Umbrella company acquiring drug companies.
Neurology
Open Jobs
16
Pipeline & Clinical Trials
No Intervention
Hemophilia aClinical Trials (1)
NCT05605678Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5)
N/AORX489 Tablets
Healthy Adult Male and Female VolunteersClinical Trials (1)
NCT07413666A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Phase 1Phase 1
Clinical Trials (1)
NCT05323110Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers
Phase 1ORX142 Tablets
Excessive Daytime SleepinessClinical Trials (1)
NCT07082829A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Phase 1Phase 1
Clinical Trials (1)
NCT04443192A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects
Phase 1LB101
Advanced Solid TumorClinical Trials (1)
NCT05821777A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors
Phase 1/2SerpinPC
Hemophilia aClinical Trials (1)
NCT04073498The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)
Phase 1/2ORX750
Narcolepsy Type 1Clinical Trials (1)
NCT07096674A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2SerpinPC
Hemophilia B with InhibitorClinical Trials (1)
NCT05789537A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors
Phase 2Imgatuzumab
Cutaneous Squamous Cell CarcinomaClinical Trials (1)
NCT04985825Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Phase 2ORX750
Narcolepsy Type 1Clinical Trials (1)
NCT06752668A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Phase 2SerpinPC
Hemophilia aClinical Trials (1)
NCT05789524The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B
Phase 2Lixivaptan
Polycystic Kidney Disease, AdultClinical Trials (1)
NCT04152837Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
Phase 3SerpinPC
Hemophilia aClinical Trials (1)
NCT06568302The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
Phase 3Lixivaptan
Autosomal Dominant Polycystic KidneyClinical Trials (1)
NCT04064346Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
Phase 3Lixivaptan
Polycystic Kidney Disease, AdultClinical Trials (1)
NCT05208866Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303
Phase 3Open Jobs (16)
Sr. Scientist, Drug Safety (Pharmacovigilance)
Boston, MA
Clinical Development3h ago
$145K - $190K/yr
Scientist, Drug Safety (Pharmacovigilance)
Boston, MA
Clinical Development3h ago
$120K - $157K/yr
Executive Director, CMC
Supply Chain
7h ago
$285K - $370K/yr
(Associate) Director, Cloud Services & Cybersecurity Operations
Boston, MA
IT9h ago
$170K - $210K/yr
Senior Director, Legal
Boston, MA
LegalYesterday
$235K - $310K/yr
(Senior) Manager, Statistical Programming
Boston, MA
Biostatistics5d ago
$120K - $157K/yr
(Associate) Director, Clinical Supply Chain
Boston, MA
Supply Chain5d ago
$170K - $205K/yr
Director, Program Management
Boston, MA
Program Management6d ago
$190K - $250K/yr
Director, Medical Affairs Operations
Boston, MA
Medical Affairs1w ago
$190K - $250K/yr
Associate Director, Toxicology
Boston, MA
Non-Clinical1w ago
$170K - $225K/yr
Senior Director, DMPK Project Leader
Boston, MA
Non-Clinical2w ago
$235K - $310K/yr
(Associate) Director, Biostatistics
Boston, MA
Biostatistics3w ago
$190K - $250K/yr
(Sr.) Manager, Clinical Supply Chain
Boston, MA
Supply Chain4w ago
$120K - $157K/yr
Senior Medical Science Liaison - West
San Francisco
Medical Affairs1mo ago
$190K - $250K/yr
Senior Medical Science Liaison (MSL) - Northeast
Boston, MA
Medical Affairs1mo ago
$190K - $250K/yr
Executive Director, Regulatory CMC
Boston, MA
Regulatory Affairs1mo ago
$285K - $370K/yr
Interview Prep Quick Facts
Portfolio: 16 clinical trials
Top TAs: Oncology
Open Roles: 16 active jobs
Hiring Trend
Actively Hiring
16
Open Roles
+8
Added
-1
Filled/Removed
Based on last 4 crawl cycles